ArticleEuropean urology open science2023

Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer.

Giuseppe Fallara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.